Skip to Main ContentSkip to FooterSkip to Search
Main menu
  1. Home
  2.  » 
  3. Expert Content
  4.  » CDMO Playbook for Scaling the Emerging Biotech Companies
Icon of a chart

CDMO Playbook for Scaling the Emerging Biotech Companies

Summary: Determining a client’s primary goal is critical to guiding them through the development of their asset. Additionally, their primary focus will impact the strategy used to develop the asset. This presentation focuses on approaches that can ensure the best success for your clients.

Alan F. Parr, Pharm.D., Ph.D., BioCeutics, LLC is former Director of Biopharmaceutics at GSK and has had various roles in big pharma included formulation scientist and formulation manager. He has worked in the field of Pharmaceutical Sciences for 33 years and responsibilities ranged from development of formulations from the early development through to scale up of commercial size batches.

Click here to view the presentation